Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 105 | $40,424,732 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
16 Oct 2024 18:53 | HALO | HALOZYME THERAPEUTICS Inc | LABARRE MICHAEL J. | SVP, CHIEF TECHNICAL OFFICER | 15 Oct 2024 | Sale | 9,923 | 53.743 | 533,292 | D |
16 Oct 2024 18:53 | HALO | HALOZYME THERAPEUTICS Inc | LABARRE MICHAEL J. | SVP, CHIEF TECHNICAL OFFICER | 15 Oct 2024 | Sale | 77 | 54.245 | 4,177 | D |
16 Oct 2024 18:53 | HALO | HALOZYME THERAPEUTICS Inc | LABARRE MICHAEL J. | SVP, CHIEF TECHNICAL OFFICER | 16 Oct 2024 | Sale | 10,000 | 53.259 | 532,590 | D |
09 Oct 2024 17:39 | HALO | HALOZYME THERAPEUTICS Inc | TORLEY HELEN | PRESIDENT AND CEO | 08 Oct 2024 | Sale | 9,100 | 53.939 | 490,845 | D |
09 Oct 2024 17:39 | HALO | HALOZYME THERAPEUTICS Inc | TORLEY HELEN | PRESIDENT AND CEO | 08 Oct 2024 | Sale | 900 | 54.573 | 49,116 | D |
09 Oct 2024 17:39 | HALO | HALOZYME THERAPEUTICS Inc | TORLEY HELEN | PRESIDENT AND CEO | 09 Oct 2024 | Sale | 5,981 | 51.847 | 310,097 | D |
09 Oct 2024 17:39 | HALO | HALOZYME THERAPEUTICS Inc | TORLEY HELEN | PRESIDENT AND CEO | 09 Oct 2024 | Sale | 1,615 | 53.31 | 86,096 | D |
09 Oct 2024 17:39 | HALO | HALOZYME THERAPEUTICS Inc | TORLEY HELEN | PRESIDENT AND CEO | 09 Oct 2024 | Sale | 2,404 | 53.906 | 129,590 | D |
26 Sep 2024 18:06 | HALO | HALOZYME THERAPEUTICS Inc | TORLEY HELEN | PRESIDENT AND CEO | 26 Sep 2024 | Sale | 10,000 | 56.097 | 560,970 | D |
26 Sep 2024 18:06 | HALO | HALOZYME THERAPEUTICS Inc | TORLEY HELEN | PRESIDENT AND CEO | 25 Sep 2024 | Sale | 10,000 | 56.337 | 563,370 | D |
26 Sep 2024 18:06 | HALO | HALOZYME THERAPEUTICS Inc | TORLEY HELEN | PRESIDENT AND CEO | 24 Sep 2024 | Sale | 10,000 | 58.21 | 582,100 | D |
18 Sep 2024 18:49 | HALO | HALOZYME THERAPEUTICS Inc | LABARRE MICHAEL J. | SVP, CHIEF TECHNICAL OFFICER | 18 Sep 2024 | Sale | 2,037 | 62.581 | 127,477 | D |
18 Sep 2024 18:49 | HALO | HALOZYME THERAPEUTICS Inc | LABARRE MICHAEL J. | SVP, CHIEF TECHNICAL OFFICER | 18 Sep 2024 | Sale | 7,963 | 61.891 | 492,838 | D |
18 Sep 2024 18:49 | HALO | HALOZYME THERAPEUTICS Inc | LABARRE MICHAEL J. | SVP, CHIEF TECHNICAL OFFICER | 17 Sep 2024 | Sale | 10,000 | 62.878 | 628,780 | D |
12 Sep 2024 17:56 | HALO | HALOZYME THERAPEUTICS Inc | TORLEY HELEN | PRESIDENT AND CEO | 12 Sep 2024 | Sale | 10,000 | 59.203 | 592,030 | D |
12 Sep 2024 17:56 | HALO | HALOZYME THERAPEUTICS Inc | TORLEY HELEN | PRESIDENT AND CEO | 11 Sep 2024 | Sale | 10,000 | 59.087 | 590,870 | D |
12 Sep 2024 17:56 | HALO | HALOZYME THERAPEUTICS Inc | TORLEY HELEN | PRESIDENT AND CEO | 10 Sep 2024 | Sale | 10,000 | 59.089 | 590,890 | D |
21 Aug 2024 18:03 | HALO | HALOZYME THERAPEUTICS Inc | LABARRE MICHAEL J. | SVP, CHIEF TECHNICAL OFFICER | 21 Aug 2024 | Sale | 100 | 62.34 | 6,234 | D |
21 Aug 2024 18:03 | HALO | HALOZYME THERAPEUTICS Inc | LABARRE MICHAEL J. | SVP, CHIEF TECHNICAL OFFICER | 21 Aug 2024 | Sale | 9,900 | 61.741 | 611,236 | D |
21 Aug 2024 18:03 | HALO | HALOZYME THERAPEUTICS Inc | LABARRE MICHAEL J. | SVP, CHIEF TECHNICAL OFFICER | 20 Aug 2024 | Sale | 10,000 | 61.055 | 610,550 | D |
15 Aug 2024 16:59 | HALO | HALOZYME THERAPEUTICS Inc | TORLEY HELEN | PRESIDENT AND CEO | 15 Aug 2024 | Sale | 10,000 | 57.949 | 579,490 | D |
15 Aug 2024 16:59 | HALO | HALOZYME THERAPEUTICS Inc | TORLEY HELEN | PRESIDENT AND CEO | 14 Aug 2024 | Sale | 200 | 58.17 | 11,634 | D |
15 Aug 2024 16:59 | HALO | HALOZYME THERAPEUTICS Inc | TORLEY HELEN | PRESIDENT AND CEO | 14 Aug 2024 | Sale | 6,537 | 57.732 | 377,394 | D |
15 Aug 2024 16:59 | HALO | HALOZYME THERAPEUTICS Inc | TORLEY HELEN | PRESIDENT AND CEO | 14 Aug 2024 | Sale | 3,263 | 56.219 | 183,443 | D |
15 Aug 2024 16:59 | HALO | HALOZYME THERAPEUTICS Inc | TORLEY HELEN | PRESIDENT AND CEO | 13 Aug 2024 | Sale | 10,000 | 56.249 | 562,490 | D |
14 Aug 2024 16:57 | HALO | HALOZYME THERAPEUTICS Inc | POSARD MATTHEW L. | Director | 14 Aug 2024 | Sale | 9,881 | 57.7 | 570,134 | D |
14 Aug 2024 16:57 | HALO | HALOZYME THERAPEUTICS Inc | POSARD MATTHEW L. | Director | 13 Aug 2024 | Sale | 10,000 | 56.193 | 561,930 | D |
14 Aug 2024 16:57 | HALO | HALOZYME THERAPEUTICS Inc | POSARD MATTHEW L. | Director | 12 Aug 2024 | Sale | 10,000 | 55.723 | 557,230 | D |
24 Jul 2024 17:48 | HALO | HALOZYME THERAPEUTICS Inc | LABARRE MICHAEL J. | SVP, CHIEF TECHNICAL OFFICER | 24 Jul 2024 | Sale | 10,000 | 55.115 | 551,150 | D |
24 Jul 2024 17:48 | HALO | HALOZYME THERAPEUTICS Inc | LABARRE MICHAEL J. | SVP, CHIEF TECHNICAL OFFICER | 23 Jul 2024 | Sale | 5,291 | 55.265 | 292,407 | D |
24 Jul 2024 17:48 | HALO | HALOZYME THERAPEUTICS Inc | LABARRE MICHAEL J. | SVP, CHIEF TECHNICAL OFFICER | 23 Jul 2024 | Sale | 4,709 | 54.463 | 256,466 | D |
23 Jul 2024 16:37 | HALO | HALOZYME THERAPEUTICS Inc | LABROSSE NICOLE | SVP, CHIEF FINANCIAL OFFICER | 22 Jul 2024 | Sale | 992 | 54.253 | 53,819 | D |
23 Jul 2024 16:37 | HALO | HALOZYME THERAPEUTICS Inc | LABROSSE NICOLE | SVP, CHIEF FINANCIAL OFFICER | 22 Jul 2024 | Sale | 4,008 | 53.853 | 215,843 | D |
28 Jun 2024 16:06 | HALO | HALOZYME THERAPEUTICS Inc | LABROSSE NICOLE | SVP, CHIEF FINANCIAL OFFICER | 28 Jun 2024 | Sale | 10,000 | 52.04 | 520,400 | D |
28 Jun 2024 16:06 | HALO | HALOZYME THERAPEUTICS Inc | LABROSSE NICOLE | SVP, CHIEF FINANCIAL OFFICER | 27 Jun 2024 | Sale | 10,000 | 51.934 | 519,340 | D |
28 Jun 2024 16:06 | HALO | HALOZYME THERAPEUTICS Inc | LABROSSE NICOLE | SVP, CHIEF FINANCIAL OFFICER | 26 Jun 2024 | Sale | 10,000 | 51.82 | 518,200 | D |
20 Jun 2024 16:17 | HALO | HALOZYME THERAPEUTICS Inc | LABARRE MICHAEL J. | SVP, CHIEF TECHNICAL OFFICER | 18 Jun 2024 | Sale | 10,000 | 49.426 | 494,260 | D |
13 Jun 2024 16:15 | HALO | HALOZYME THERAPEUTICS Inc | POSARD MATTHEW L. | Director | 12 Jun 2024 | Sale | 10,000 | 50.619 | 506,190 | D |
13 Jun 2024 16:15 | HALO | HALOZYME THERAPEUTICS Inc | POSARD MATTHEW L. | Director | 11 Jun 2024 | Sale | 10,000 | 50.011 | 500,110 | D |
22 May 2024 17:24 | HALO | HALOZYME THERAPEUTICS Inc | LABARRE MICHAEL J. | SVP, CHIEF TECHNICAL OFFICER | 21 May 2024 | Sale | 10,000 | 45.164 | 451,640 | D |
22 May 2024 17:24 | HALO | HALOZYME THERAPEUTICS Inc | LABARRE MICHAEL J. | SVP, CHIEF TECHNICAL OFFICER | 22 May 2024 | Sale | 10,000 | 45.384 | 453,840 | D |
17 Apr 2024 19:22 | HALO | HALOZYME THERAPEUTICS Inc | LABARRE MICHAEL J. | SVP, CHIEF TECHNICAL OFFICER | 17 Apr 2024 | Sale | 10,000 | 38.489 | 384,890 | D |
17 Apr 2024 19:22 | HALO | HALOZYME THERAPEUTICS Inc | LABARRE MICHAEL J. | SVP, CHIEF TECHNICAL OFFICER | 16 Apr 2024 | Sale | 10,000 | 38.35 | 383,500 | D |
13 Mar 2024 17:22 | HALO | HALOZYME THERAPEUTICS Inc | LABARRE MICHAEL J. | SVP, CHIEF TECHNICAL OFFICER | 13 Mar 2024 | Sale | 10,000 | 42.273 | 422,730 | D |
13 Mar 2024 17:22 | HALO | HALOZYME THERAPEUTICS Inc | LABARRE MICHAEL J. | SVP, CHIEF TECHNICAL OFFICER | 12 Mar 2024 | Sale | 10,000 | 41.637 | 416,370 | D |
28 Feb 2024 18:49 | HALO | HALOZYME THERAPEUTICS Inc | LABARRE MICHAEL J. | SVP, CHIEF TECHNICAL OFFICER | 28 Feb 2024 | Sale | 7,471 | 39.542 | 295,418 | D |
28 Feb 2024 18:49 | HALO | HALOZYME THERAPEUTICS Inc | LABARRE MICHAEL J. | SVP, CHIEF TECHNICAL OFFICER | 28 Feb 2024 | Sale | 2,529 | 39.559 | 100,045 | D |
28 Feb 2024 18:49 | HALO | HALOZYME THERAPEUTICS Inc | LABARRE MICHAEL J. | SVP, CHIEF TECHNICAL OFFICER | 27 Feb 2024 | Sale | 10,000 | 39.946 | 399,460 | D |
18 Jan 2024 16:07 | HALO | HALOZYME THERAPEUTICS Inc | LABARRE MICHAEL J. | SVP, CHIEF TECHNICAL OFFICER | 17 Jan 2024 | Sale | 10,000 | 36 | 360,000 | D |
18 Jan 2024 16:07 | HALO | HALOZYME THERAPEUTICS Inc | LABARRE MICHAEL J. | SVP, CHIEF TECHNICAL OFFICER | 16 Jan 2024 | Sale | 10,000 | 36 | 360,000 | D |
13 Dec 2023 19:48 | HALO | HALOZYME THERAPEUTICS Inc | LABARRE MICHAEL J. | SVP, CHIEF TECHNICAL OFFICER | 13 Dec 2023 | Sale | 10,000 | 40.394 | 403,940 | D |
13 Dec 2023 19:48 | HALO | HALOZYME THERAPEUTICS Inc | LABARRE MICHAEL J. | SVP, CHIEF TECHNICAL OFFICER | 12 Dec 2023 | Sale | 9,357 | 39.575 | 370,303 | D |
13 Dec 2023 19:48 | HALO | HALOZYME THERAPEUTICS Inc | LABARRE MICHAEL J. | SVP, CHIEF TECHNICAL OFFICER | 12 Dec 2023 | Sale | 643 | 40.465 | 26,019 | D |
16 Nov 2023 16:18 | HALO | HALOZYME THERAPEUTICS Inc | LABARRE MICHAEL J. | SVP, CHIEF TECHNICAL OFFICER | 15 Nov 2023 | Sale | 10,000 | 39.788 | 397,880 | D |
16 Nov 2023 16:18 | HALO | HALOZYME THERAPEUTICS Inc | LABARRE MICHAEL J. | SVP, CHIEF TECHNICAL OFFICER | 14 Nov 2023 | Sale | 8,292 | 39.079 | 324,043 | D |
16 Nov 2023 16:18 | HALO | HALOZYME THERAPEUTICS Inc | LABARRE MICHAEL J. | SVP, CHIEF TECHNICAL OFFICER | 14 Nov 2023 | Sale | 1,708 | 39.079 | 66,747 | D |
17 Oct 2023 19:28 | HALO | HALOZYME THERAPEUTICS Inc | LABARRE MICHAEL J. | SVP, CHIEF TECHNICAL OFFICER | 17 Oct 2023 | Sale | 10,000 | 36.52 | 365,200 | D |
19 Sep 2023 16:09 | HALO | HALOZYME THERAPEUTICS Inc | LABARRE MICHAEL J. | SVP, CHIEF TECHNICAL OFFICER | 19 Sep 2023 | Sale | 10,000 | 39.098 | 390,980 | D |
31 Aug 2023 17:35 | HALO | HALOZYME THERAPEUTICS Inc | TORLEY HELEN | PRESIDENT AND CEO | 31 Aug 2023 | Sale | 10,000 | 42.817 | 428,170 | D |
31 Aug 2023 17:35 | HALO | HALOZYME THERAPEUTICS Inc | TORLEY HELEN | PRESIDENT AND CEO | 30 Aug 2023 | Sale | 10,000 | 42.854 | 428,540 | D |
31 Aug 2023 17:35 | HALO | HALOZYME THERAPEUTICS Inc | TORLEY HELEN | PRESIDENT AND CEO | 29 Aug 2023 | Sale | 10,000 | 42.402 | 424,020 | D |
23 Aug 2023 17:08 | HALO | HALOZYME THERAPEUTICS Inc | LABARRE MICHAEL J. | SVP, CHIEF TECHNICAL OFFICER | 22 Aug 2023 | Sale | 8,075 | 42.407 | 342,437 | D |
23 Aug 2023 17:08 | HALO | HALOZYME THERAPEUTICS Inc | LABARRE MICHAEL J. | SVP, CHIEF TECHNICAL OFFICER | 22 Aug 2023 | Sale | 1,925 | 42.407 | 81,633 | D |
17 Aug 2023 17:29 | HALO | HALOZYME THERAPEUTICS Inc | TORLEY HELEN | PRESIDENT AND CEO | 17 Aug 2023 | Sale | 10,000 | 43.182 | 431,820 | D |
17 Aug 2023 17:29 | HALO | HALOZYME THERAPEUTICS Inc | TORLEY HELEN | PRESIDENT AND CEO | 16 Aug 2023 | Sale | 10,000 | 43.532 | 435,320 | D |
17 Aug 2023 17:29 | HALO | HALOZYME THERAPEUTICS Inc | TORLEY HELEN | PRESIDENT AND CEO | 15 Aug 2023 | Sale | 10,000 | 43.768 | 437,680 | D |
15 Aug 2023 16:04 | HALO | HALOZYME THERAPEUTICS Inc | DALY JAMES M | Director | 14 Aug 2023 | Sale | 10,000 | 43.741 | 437,410 | D |
15 Aug 2023 16:04 | HALO | HALOZYME THERAPEUTICS Inc | DALY JAMES M | Director | 11 Aug 2023 | Sale | 10,000 | 43.711 | 437,110 | D |
27 Jul 2023 16:03 | HALO | HALOZYME THERAPEUTICS Inc | TORLEY HELEN | PRESIDENT AND CEO | 27 Jul 2023 | Sale | 10,000 | 43.79 | 437,900 | D |
27 Jul 2023 16:03 | HALO | HALOZYME THERAPEUTICS Inc | TORLEY HELEN | PRESIDENT AND CEO | 26 Jul 2023 | Sale | 10,000 | 42.689 | 426,890 | D |
27 Jul 2023 16:03 | HALO | HALOZYME THERAPEUTICS Inc | TORLEY HELEN | PRESIDENT AND CEO | 25 Jul 2023 | Sale | 10,000 | 42.796 | 427,960 | D |
19 Jul 2023 16:10 | HALO | HALOZYME THERAPEUTICS Inc | LABARRE MICHAEL J. | SVP, CHIEF TECHNICAL OFFICER | 18 Jul 2023 | Sale | 10,000 | 40.43 | 404,300 | D |
22 Jun 2023 18:20 | HALO | HALOZYME THERAPEUTICS Inc | LABARRE MICHAEL J. | SVP, CHIEF TECHNICAL OFFICER | 21 Jun 2023 | Sale | 10,000 | 36 | 360,000 | D |
19 Apr 2023 18:07 | HALO | HALOZYME THERAPEUTICS Inc | LABARRE MICHAEL J. | SVP, CHIEF TECHNICAL OFFICER | 18 Apr 2023 | Sale | 10,000 | 36 | 360,000 | D |
19 Apr 2023 18:01 | HALO | HALOZYME THERAPEUTICS Inc | LABARRE MICHAEL J. | SVP, CHIEF TECHNICAL OFFICER | 27 Feb 2023 | Sale A | 2,984 | 49.549 | 147,854 | D |
09 Mar 2023 17:04 | HALO | HALOZYME THERAPEUTICS Inc | TORLEY HELEN | PRESIDENT AND CEO | 09 Mar 2023 | Sale | 10,000 | 42.727 | 427,270 | D |
09 Mar 2023 17:04 | HALO | HALOZYME THERAPEUTICS Inc | TORLEY HELEN | PRESIDENT AND CEO | 08 Mar 2023 | Sale | 10,000 | 43.259 | 432,590 | D |
09 Mar 2023 17:04 | HALO | HALOZYME THERAPEUTICS Inc | TORLEY HELEN | PRESIDENT AND CEO | 07 Mar 2023 | Sale | 10,000 | 45.469 | 454,690 | D |
01 Mar 2023 18:07 | HALO | HALOZYME THERAPEUTICS Inc | HENDERSON JEFFREY WILLIAM | Director | 01 Mar 2023 | Sale | 10,000 | 47.71 | 477,100 | D |
01 Mar 2023 18:07 | HALO | HALOZYME THERAPEUTICS Inc | HENDERSON JEFFREY WILLIAM | Director | 28 Feb 2023 | Sale | 10,000 | 48.51 | 485,100 | D |
28 Feb 2023 16:59 | HALO | HALOZYME THERAPEUTICS Inc | LABARRE MICHAEL J. | SVP, CHIEF TECHNICAL OFFICER | 27 Feb 2023 | Sale | 2,984 | 49.549 | 147,854 | D |
28 Feb 2023 16:59 | HALO | HALOZYME THERAPEUTICS Inc | LABARRE MICHAEL J. | SVP, CHIEF TECHNICAL OFFICER | 27 Feb 2023 | Sale | 7,016 | 49.548 | 347,629 | D |
21 Feb 2023 19:05 | HALO | HALOZYME THERAPEUTICS Inc | LABARRE MICHAEL J. | SVP, CHIEF TECHNICAL OFFICER | 16 Feb 2023 | Sale | 2,878 | 49.26 | 141,770 | D |
21 Feb 2023 19:00 | HALO | HALOZYME THERAPEUTICS Inc | LABROSSE NICOLE | SVP, CHIEF FINANCIAL OFFICER | 16 Feb 2023 | Sale | 2,525 | 49.26 | 124,382 | D |
21 Feb 2023 18:59 | HALO | HALOZYME THERAPEUTICS Inc | TORLEY HELEN | PRESIDENT AND CEO | 16 Feb 2023 | Sale | 11,061 | 49.26 | 544,865 | D |
17 Feb 2023 06:29 | HALO | HALOZYME THERAPEUTICS Inc | LABARRE MICHAEL J. | SVP, CHIEF TECHNICAL OFFICER | 15 Feb 2023 | Sale | 10,000 | 48.394 | 483,940 | D |
09 Feb 2023 17:44 | HALO | HALOZYME THERAPEUTICS Inc | TORLEY HELEN | PRESIDENT AND CEO | 09 Feb 2023 | Sale | 10,000 | 50.4 | 504,000 | D |
09 Feb 2023 17:44 | HALO | HALOZYME THERAPEUTICS Inc | TORLEY HELEN | PRESIDENT AND CEO | 08 Feb 2023 | Sale | 10,000 | 51.357 | 513,570 | D |
09 Feb 2023 17:44 | HALO | HALOZYME THERAPEUTICS Inc | TORLEY HELEN | PRESIDENT AND CEO | 07 Feb 2023 | Sale | 10,000 | 51.258 | 512,580 | D |
19 Jan 2023 17:07 | HALO | HALOZYME THERAPEUTICS Inc | TORLEY HELEN | PRESIDENT AND CEO | 19 Jan 2023 | Sale | 10,000 | 52.414 | 524,140 | D |
19 Jan 2023 17:07 | HALO | HALOZYME THERAPEUTICS Inc | TORLEY HELEN | PRESIDENT AND CEO | 18 Jan 2023 | Sale | 10,000 | 51.047 | 510,470 | D |
19 Jan 2023 17:07 | HALO | HALOZYME THERAPEUTICS Inc | TORLEY HELEN | PRESIDENT AND CEO | 17 Jan 2023 | Sale | 1,103 | 50.929 | 56,175 | D |
19 Jan 2023 17:07 | HALO | HALOZYME THERAPEUTICS Inc | TORLEY HELEN | PRESIDENT AND CEO | 17 Jan 2023 | Sale | 8,897 | 50.395 | 448,364 | D |
18 Jan 2023 19:07 | HALO | HALOZYME THERAPEUTICS Inc | LABARRE MICHAEL J. | SVP, CHIEF TECHNICAL OFFICER | 17 Jan 2023 | Sale | 1,122 | 50.926 | 57,139 | D |
18 Jan 2023 19:07 | HALO | HALOZYME THERAPEUTICS Inc | LABARRE MICHAEL J. | SVP, CHIEF TECHNICAL OFFICER | 17 Jan 2023 | Sale | 8,878 | 50.4 | 447,451 | D |
15 Dec 2022 19:12 | HALO | HALOZYME THERAPEUTICS Inc | TORLEY HELEN | PRESIDENT AND CEO | 15 Dec 2022 | Sale | 896 | 58.197 | 52,145 | D |
15 Dec 2022 19:12 | HALO | HALOZYME THERAPEUTICS Inc | TORLEY HELEN | PRESIDENT AND CEO | 15 Dec 2022 | Sale | 9,104 | 57.288 | 521,550 | D |
15 Dec 2022 19:12 | HALO | HALOZYME THERAPEUTICS Inc | TORLEY HELEN | PRESIDENT AND CEO | 14 Dec 2022 | Sale | 10,000 | 58.298 | 582,980 | D |
15 Dec 2022 19:12 | HALO | HALOZYME THERAPEUTICS Inc | TORLEY HELEN | PRESIDENT AND CEO | 13 Dec 2022 | Sale | 493 | 59.12 | 29,146 | D |
15 Dec 2022 19:12 | HALO | HALOZYME THERAPEUTICS Inc | TORLEY HELEN | PRESIDENT AND CEO | 13 Dec 2022 | Sale | 9,507 | 58.639 | 557,481 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)